Frazier Life Sciences Management, L.P. — MAZE THERAPEUTICS INC MAZE: Quarterly 13F Position History
Frazier Life Sciences Management, L.P. has reported MAZE THERAPEUTICS INC (MAZE) on 5 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2025. As of Q1 2026, the position is sized at 4,567,274 shares ($136.3M market value, 3.51% of the equity book).
- 4,567,274Shares Held (Latest Filing)
- $136.3MReported Market Value (Latest Filing)
- 3.51%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$52.9MQuarter-over-Quarter Value Change
- 4,567,275Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 4,567,274 | 0 | — | $136.3M | 3.51% | $29.85 |
| Q4 2025 | 4,567,274 | 0 | — | $189.2M | 5.08% | $41.43 |
| Q3 2025 | 4,567,274 | 1 | -0.0% | $118.4M | 3.55% | $25.93 |
| Q2 2025 | 4,567,275 | +438,274 | +10.6% | $56.0M | 2.24% | $12.27 |
| Q1 2025 | 4,129,001 | — | — | $45.5M | 2.08% | $11.01 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Frazier Life Sciences Management, L.P. first disclose a MAZE position in 13F-HR filings?
Frazier Life Sciences Management, L.P. first reported MAZE THERAPEUTICS INC (MAZE) on its 13F-HR filing for the period ending 2025-03-31 (Q1 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was Frazier Life Sciences Management, L.P.'s most recent quarter-over-quarter share-count change in MAZE?
Frazier Life Sciences Management, L.P. held the same 4,567,274 shares of MAZE between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent Frazier Life Sciences Management, L.P.'s cost basis in MAZE?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.